Difference (improvement or worsening) in the postoperative baseline score (preoperative) in the Portuguese version of the Quality of Recovery questionnaire 15.
Impact of the Use of Ketamine in Laparoscopic Surgery.
Brief Summary
In order to improve the postoperative period (namely pain control), several drugs can be used. For instance, ketamine is a general anesthetic that holds strong analgesic properties, yet also owns undesirable effects, in which hallucination phenomena is one the most common indicator. However, slight information is available about the real implication in the quality of the recovery on the use of ketamine for postoperative pain treatment. The quality of the recovery includes several health conditions, such as pain, physical comfort, physical independence, psychological support and emotional state. In recent years, investigations in this field has been attracted the attention by the health professionals, since is an indicator of the quality of post-operative care. To evaluate these parameters, questionnaires have been developed, in which the Portuguese version of Quality of Recovery 15 (QoR-15) is include. This questionnaire evaluates five psychometric dimensions. Therefore, the present study has the main goal, the evaluation of the effect of using ketamine in laparoscopic surgery and the quality of the recovery using the QoR-15 questionnaire.
Intervention / Treatment
-
Ketamine (DRUG)Administration of 0.5mg / kg ideal body weight of ketamine at induction of anesthesia in laparoscopic surgery.
Condition or Disease
- Quality of Recovery
Phase
Study Design
| Study type: | INTERVENTIONAL |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 18 Years to 65 Years |
| Enrollment: | 127 (ACTUAL) |
| Funded by: | Other |
| Allocation: | Non-Randomized |
| Primary Purpose: | Screening |
Masking |
|
Clinical Trial Dates
| Start date: | Oct 01, 2018 | ACTUAL |
|---|---|---|
| Primary Completion: | Oct 01, 2022 | ACTUAL |
| Completion Date: | Apr 01, 2023 | ACTUAL |
| Study First Posted: | Oct 30, 2018 | ACTUAL |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | May 09, 2023 |
Sponsors / Collaborators
Location
Participant Groups
-
20 milliliter of ketamine (0.5mg / kg ideal body weight) at induction of anesthesia.
-
No description provided
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 18 |
| Maximum Age: | 65 |
| Age Groups: | Adult / Older Adult |
| Healthy Volunteers: | Yes |
Inclusion Criteria:
* Patients between 18 and 65 years age, with an American Society of Anesthesiology physical status I, II or III.
* Laparoscopic surgery (sleeve gastrectomy, salpingectomy, or cholecystectomy)
Exclusion Criteria:
* patient refusal, the incapacity of providing informed consent, drug abusers (current or past history) or alcohol abuse, medication with benzodiazepines, inability to give informed consent, pregnant, emergency surgery, psychiatric pathology, existence of surgical complications in the recovery and admission to a level II or III unit ( for any reason).
* Patients between 18 and 65 years age, with an American Society of Anesthesiology physical status I, II or III.
* Laparoscopic surgery (sleeve gastrectomy, salpingectomy, or cholecystectomy)
Exclusion Criteria:
* patient refusal, the incapacity of providing informed consent, drug abusers (current or past history) or alcohol abuse, medication with benzodiazepines, inability to give informed consent, pregnant, emergency surgery, psychiatric pathology, existence of surgical complications in the recovery and admission to a level II or III unit ( for any reason).
Primary Outcomes
More Details
| NCT Number: | NCT03724019 |
|---|---|
| Other IDs: | QuetaminaQOR15 |
| Study URL: | https://clinicaltrials.gov/study/NCT03724019 |
Last updated: Sep 29, 2023